Publication | Closed Access

Systemic radioimmunotherapy using a monoclonal antibody, anti-Tac directed toward the alpha subunit of the IL-2 receptor armed with the α-emitting radionuclides 212Bi or 211At

AllergyImmunodeficienciesImmunologyImmune RegulationImmunodominanceTumor ImmunityImmune SurveillanceSelf-toleranceImmune SystemImmunomodulationImmunotherapeuticsSystemic RadioimmunotherapyImmunosuppressionAlpha SubunitImmunotherapyMedicineMonoclonal Antibody